Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Ratner

Showing results (81-90 of 147) with videos related to

Pageof 15
Sort By:
Life Science Alliance|March 8, 2024
C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosisMelissa R Perrino, Niousha Ahmari, Ashley Hall, et al.
Oncogene|December 9, 2020
MicroRNA-155 contributes to plexiform neurofibroma growth downstream of MEKYoujin Na, Ashley Hall, Kwangmin Choi, et al.
Nature Communications|January 10, 2015
Corrigendum: The tumour suppressor LKB1 regulates myelination through mitochondrial metabolismShabnam Pooya, Xiaona Liu, V B Sameer Kumar, et al.
Cancers|April 3, 2021
Transposon Mutagenesis-Guided CRISPR/Cas9 Screening Strongly Implicates Dysregulation of Hippo/YAP Signaling in Malignant Peripheral Nerve Sheath Tumor DevelopmentGermán L Vélez-Reyes, Nicholas Koes, Ji Hae Ryu, et al.
Cell Reports|April 20, 2017
Oligodendrocyte Nf1 Controls Aberrant Notch Activation and Regulates Myelin Structure and BehaviorAlejandro López-Juárez, Haley E Titus, Sadiq H Silbak, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostatMichaela Angelika Ihle, Sabine Merkelbach-Bruse, Wolfgang Hartmann, et al.
Acta Neuropathologica|October 27, 2012
Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibitionCarlos E Prada, Edwin Jousma, Tilat A Rizvi, et al.
Oncotarget|April 18, 2018
Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cellsRobert J Allaway, Matthew D Wood, Sondra L Downey, et al.
Nature Communications|September 27, 2014
The tumour suppressor LKB1 regulates myelination through mitochondrial metabolismShabnam Pooya, Xiaona Liu, V B Sameer Kumar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
Oncolytic HSV and erlotinib inhibit tumor growth and angiogenesis in a novel malignant peripheral nerve sheath tumor xenograft modelYonatan Y Mahller, Sachin S Vaikunth, Mark A Currier, et al.
Pageof 15

Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
Life Science Alliance|March 8, 2024
C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosisMelissa R Perrino, Niousha Ahmari, Ashley Hall, et al.
Oncogene|December 9, 2020
MicroRNA-155 contributes to plexiform neurofibroma growth downstream of MEKYoujin Na, Ashley Hall, Kwangmin Choi, et al.
Nature Communications|January 10, 2015
Corrigendum: The tumour suppressor LKB1 regulates myelination through mitochondrial metabolismShabnam Pooya, Xiaona Liu, V B Sameer Kumar, et al.
Cancers|April 3, 2021
Transposon Mutagenesis-Guided CRISPR/Cas9 Screening Strongly Implicates Dysregulation of Hippo/YAP Signaling in Malignant Peripheral Nerve Sheath Tumor DevelopmentGermán L Vélez-Reyes, Nicholas Koes, Ji Hae Ryu, et al.
Cell Reports|April 20, 2017
Oligodendrocyte Nf1 Controls Aberrant Notch Activation and Regulates Myelin Structure and BehaviorAlejandro López-Juárez, Haley E Titus, Sadiq H Silbak, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
HR23b expression is a potential predictive biomarker for HDAC inhibitor treatment in mesenchymal tumours and is associated with response to vorinostatMichaela Angelika Ihle, Sabine Merkelbach-Bruse, Wolfgang Hartmann, et al.
Acta Neuropathologica|October 27, 2012
Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibitionCarlos E Prada, Edwin Jousma, Tilat A Rizvi, et al.
Oncotarget|April 18, 2018
Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cellsRobert J Allaway, Matthew D Wood, Sondra L Downey, et al.
Nature Communications|September 27, 2014
The tumour suppressor LKB1 regulates myelination through mitochondrial metabolismShabnam Pooya, Xiaona Liu, V B Sameer Kumar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
Oncolytic HSV and erlotinib inhibit tumor growth and angiogenesis in a novel malignant peripheral nerve sheath tumor xenograft modelYonatan Y Mahller, Sachin S Vaikunth, Mark A Currier, et al.
Pageof 15